Skip to main content
Erschienen in: Neurological Sciences 7/2019

20.03.2019 | Original Article

The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson’s disease

verfasst von: Anna De Rosa, Immacolata Cristina Nettore, Elena Cantone, Luigi Maione, Silvio Desiderio, Silvio Peluso, Francesco Saccà, Fiore Manganelli, Dario Bruzzese, Annamaria Colao, Giuseppe De Michele, Paolo Emidio Macchia

Erschienen in: Neurological Sciences | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Gustatory perception has been poorly explored in Parkinson’s disease (PD). Aim of this study was to assess the flavor ability in PD patients, using the “flavor test” (FT), a new standardized and validated tool to examine the flavor perception. Thirty-eight patients (17 F and 21 M) and 36 control subjects (15 F and 21 M) comparable for age and gender were enrolled. All the subjects underwent the flavor test (FT), the Sniffin’ Sticks test (SST), and the gustometry test (GT), based on the basic four tastants (“salty,” “sour,” “sweet,” and “bitter”). PD patients presented a FT score significantly lower than controls (p < 0.001). Olfaction (SST) was impaired in PD in comparison with controls (p < 0.001), and the patients also showed a mild reduction of basic tastant identification at the GT (p = 0.08), with a trend toward statistical significance. There was no correlation between SST, FT, and GT. GT performance was negatively correlated with disease severity (p = 0.004) and stage (p = 0.024). The SST and FT resulted abnormal in PD in comparison with controls, independently of disease duration and severity. The ability to identify the basic four tastants was correlated with the disease severity and stage in PD patients suggesting that it might occur later in the course of the disease. FT might be a sensitive tool in identifying the sensorineural perception dysfunction in PD, even in the early stage and regardless of the disease severity.
Literatur
1.
Zurück zum Zitat Poewe W, Seppi K, Tanne CM et al (2017) Parkinson disease. Nat Rev Dis Primers 23(3):17013CrossRef Poewe W, Seppi K, Tanne CM et al (2017) Parkinson disease. Nat Rev Dis Primers 23(3):17013CrossRef
2.
Zurück zum Zitat Postuma RB, Berg D, Stern M et al (2007) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRef Postuma RB, Berg D, Stern M et al (2007) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRef
3.
4.
Zurück zum Zitat Lerche S, Seppi K, Behnke S, Liepelt-Scarfone I, Godau J, Mahlknecht P, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Poewe W, Berg D (2014) Risk factors and prodromal markers and the development of Parkinson’s disease. J Neurol 261(1):180–187CrossRefPubMed Lerche S, Seppi K, Behnke S, Liepelt-Scarfone I, Godau J, Mahlknecht P, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Poewe W, Berg D (2014) Risk factors and prodromal markers and the development of Parkinson’s disease. J Neurol 261(1):180–187CrossRefPubMed
5.
Zurück zum Zitat Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211CrossRef Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211CrossRef
6.
7.
Zurück zum Zitat Tarakad A, Jankovic J (2017) Anosmia and ageusia in Parkinson’s disease. Int Rev Neurobiol 133:541–556CrossRefPubMed Tarakad A, Jankovic J (2017) Anosmia and ageusia in Parkinson’s disease. Int Rev Neurobiol 133:541–556CrossRefPubMed
8.
Zurück zum Zitat Burdach KJ, Doty RL (1987) The effects of mouth movements, swallowing, and spitting on retronasal odor perception. Physiol Behav 41(4):353–356CrossRefPubMed Burdach KJ, Doty RL (1987) The effects of mouth movements, swallowing, and spitting on retronasal odor perception. Physiol Behav 41(4):353–356CrossRefPubMed
9.
Zurück zum Zitat Maione L, Cantone E, Nettore IC, Cerbone G, de Brasi D, Maione N, Young J, di Somma C, Sinisi AA, Iengo M, Macchia PE, Pivonello R, Colao A (2016) Flavor perception test: evaluation in patients with Kallmann syndrome. Endocrine 52(2):236–243CrossRefPubMed Maione L, Cantone E, Nettore IC, Cerbone G, de Brasi D, Maione N, Young J, di Somma C, Sinisi AA, Iengo M, Macchia PE, Pivonello R, Colao A (2016) Flavor perception test: evaluation in patients with Kallmann syndrome. Endocrine 52(2):236–243CrossRefPubMed
10.
Zurück zum Zitat Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264(3):237–243CrossRefPubMed Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264(3):237–243CrossRefPubMed
11.
Zurück zum Zitat Kobal G, Klimek L, Wolfensberger M et al (2000) Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arc Otorhinolaryngol 275(4):205–211CrossRef Kobal G, Klimek L, Wolfensberger M et al (2000) Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arc Otorhinolaryngol 275(4):205–211CrossRef
12.
Zurück zum Zitat Pingel J, Ostwald J, Pau HW, Hummel T, Just T (2010) Normative data for a solution-based taste test. Eur Arch Otorhinolaryngol 267(12):1911–1917CrossRefPubMed Pingel J, Ostwald J, Pau HW, Hummel T, Just T (2010) Normative data for a solution-based taste test. Eur Arch Otorhinolaryngol 267(12):1911–1917CrossRefPubMed
13.
Zurück zum Zitat Small DM, Prescott J (2005) Odor/taste integration and the perception of flavor. Exp Brain Res 166(3–4):345–357CrossRefPubMed Small DM, Prescott J (2005) Odor/taste integration and the perception of flavor. Exp Brain Res 166(3–4):345–357CrossRefPubMed
14.
Zurück zum Zitat Di Salle F, Cantone E, Savarese MF et al (2013) Effect of carbonation on brain processing of sweet stimuli in humans. Gastroenterology 145(3):537–539CrossRefPubMed Di Salle F, Cantone E, Savarese MF et al (2013) Effect of carbonation on brain processing of sweet stimuli in humans. Gastroenterology 145(3):537–539CrossRefPubMed
15.
Zurück zum Zitat Shah M, Deeb J, Fernando M, Noyce A, Visentin E, Findley LJ, Hawkes CH (2009) Abnormality of taste and smell in Parkinson’s disease. Parkinsonism Relat Disord 15:232–237CrossRefPubMed Shah M, Deeb J, Fernando M, Noyce A, Visentin E, Findley LJ, Hawkes CH (2009) Abnormality of taste and smell in Parkinson’s disease. Parkinsonism Relat Disord 15:232–237CrossRefPubMed
16.
Zurück zum Zitat Deeb J, Shah M, Muhammed N, Gunasekera R, Gannon K, Findley LG, Hawkes CH (2010) A basic smell test is a sensitive as dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson’s disease. QJMed 103:941–952CrossRef Deeb J, Shah M, Muhammed N, Gunasekera R, Gannon K, Findley LG, Hawkes CH (2010) A basic smell test is a sensitive as dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson’s disease. QJMed 103:941–952CrossRef
17.
Zurück zum Zitat Cecchini MP, Osculati F, Ottaviani S, Boschi F, Fasano A, Tinazzi M (2014) Taste performance in Parkinson’s disease. J Neural Transm 21:119–122CrossRef Cecchini MP, Osculati F, Ottaviani S, Boschi F, Fasano A, Tinazzi M (2014) Taste performance in Parkinson’s disease. J Neural Transm 21:119–122CrossRef
18.
Zurück zum Zitat Roos DS, Oranje OJM, Freriksen AFD, Berendse HW, Boesveldt S (2018) Flavor perception and the risk of malnutrition in patients with Parkinson’s disease. J Neural Transm 125(6):925–930CrossRefPubMed Roos DS, Oranje OJM, Freriksen AFD, Berendse HW, Boesveldt S (2018) Flavor perception and the risk of malnutrition in patients with Parkinson’s disease. J Neural Transm 125(6):925–930CrossRefPubMed
19.
Zurück zum Zitat Ricatti MJ, Ottaviani S, Boschi F, Fasano A, Tinazzi M, Cecchini MP (2017) A prospective evaluation of taste in Parkinson’s disease. J Neural Transm 124(3):347–352CrossRefPubMed Ricatti MJ, Ottaviani S, Boschi F, Fasano A, Tinazzi M, Cecchini MP (2017) A prospective evaluation of taste in Parkinson’s disease. J Neural Transm 124(3):347–352CrossRefPubMed
20.
Zurück zum Zitat Garcia-Esparcia P, Schlüter A, Carmona M, Moreno J, Ansoleaga B, Torrejón-Escribano B, Gustincich S, Pujol A, Ferrer I (2013) Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain. J Neuropathol Exp Neurol 72(6):524–539CrossRef Garcia-Esparcia P, Schlüter A, Carmona M, Moreno J, Ansoleaga B, Torrejón-Escribano B, Gustincich S, Pujol A, Ferrer I (2013) Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain. J Neuropathol Exp Neurol 72(6):524–539CrossRef
21.
Zurück zum Zitat Sienkiewicz-Jarosz H, Scinska A, Swiecicki L, Lipczynska-Lojkowska W, Kuran W, Ryglewicz D, Kolaczkowski M, Samochowiec J, Bienkowski P (2013) Sweet liking in patients with Parkinson’s disease. Neurol Sci 329:17–22CrossRef Sienkiewicz-Jarosz H, Scinska A, Swiecicki L, Lipczynska-Lojkowska W, Kuran W, Ryglewicz D, Kolaczkowski M, Samochowiec J, Bienkowski P (2013) Sweet liking in patients with Parkinson’s disease. Neurol Sci 329:17–22CrossRef
22.
Zurück zum Zitat Boesveldt S, Verbaan D, Knol DL, Visser M, van Rooden SM, van Hilten JJ, Berendse HW (2008) A comparative study of odor identification and odor discrimination deficits in Parkinson’s disease. Mov Disord 23(14):1984–1990CrossRefPubMed Boesveldt S, Verbaan D, Knol DL, Visser M, van Rooden SM, van Hilten JJ, Berendse HW (2008) A comparative study of odor identification and odor discrimination deficits in Parkinson’s disease. Mov Disord 23(14):1984–1990CrossRefPubMed
23.
Zurück zum Zitat Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244CrossRefPubMed Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244CrossRefPubMed
24.
Zurück zum Zitat Casjens S, Eckert A, Woitalla D et al (2013) Diagnostic value of the impairment of olfaction in Parkinson’s disease. PLoS One 16:e64735CrossRef Casjens S, Eckert A, Woitalla D et al (2013) Diagnostic value of the impairment of olfaction in Parkinson’s disease. PLoS One 16:e64735CrossRef
25.
Zurück zum Zitat Liu R, Umbach DM, Peddada SD, Xu Z, Troster AI, Huang X, Chen H (2015) Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease. Neurology 84(21):2107–2115CrossRefPubMedPubMedCentral Liu R, Umbach DM, Peddada SD, Xu Z, Troster AI, Huang X, Chen H (2015) Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease. Neurology 84(21):2107–2115CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Ondo WG, Lai D (2005) Olfaction testing in patients with tremor-dominant Parkinson’s disease: is this a distinct condition? Mov Disord 20(4):471–475CrossRefPubMed Ondo WG, Lai D (2005) Olfaction testing in patients with tremor-dominant Parkinson’s disease: is this a distinct condition? Mov Disord 20(4):471–475CrossRefPubMed
27.
Zurück zum Zitat Del Tredici K, Braak H (2016) Sporadic Parkinson’s disease: development and distribution of α-synuclein pathology. Neuropathol Appl Neurobiol 42(1):33–50CrossRefPubMed Del Tredici K, Braak H (2016) Sporadic Parkinson’s disease: development and distribution of α-synuclein pathology. Neuropathol Appl Neurobiol 42(1):33–50CrossRefPubMed
28.
Zurück zum Zitat Heckmann JG, Heckmann SM, Lang CJ, Hummel T (2003) Neurological aspects of taste disorders. Arch Neurol 60(5):667–671CrossRefPubMed Heckmann JG, Heckmann SM, Lang CJ, Hummel T (2003) Neurological aspects of taste disorders. Arch Neurol 60(5):667–671CrossRefPubMed
Metadaten
Titel
The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson’s disease
verfasst von
Anna De Rosa
Immacolata Cristina Nettore
Elena Cantone
Luigi Maione
Silvio Desiderio
Silvio Peluso
Francesco Saccà
Fiore Manganelli
Dario Bruzzese
Annamaria Colao
Giuseppe De Michele
Paolo Emidio Macchia
Publikationsdatum
20.03.2019
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 7/2019
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-03842-2

Weitere Artikel der Ausgabe 7/2019

Neurological Sciences 7/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.